STUDIES ON THE ABSORPTION OF ANTICANCER AGENTS THROUGH THE BLADDER - BASIS OF THE INSTILLATION THERAPY - 3.URINARY EXCRETION AND VESICAL TISSUE CONCENTRATION OF THE INSTILLED ADRIAMYCIN IN THE PATIENTS WITH BLADDER CANCER by 永田, 一夫
Title抗癌剤の経膀胱的吸収に関する研究 -膀胱内注入療法の基礎- 第3報 Adriamycinの膀胱腫瘍組織内濃度
Author(s)永田, 一夫




Type Departmental Bulletin Paper
Textversionpublisher
Kyoto University






       永  田  一  夫
STUDIES ON THE ABSORPTION OF ANTICANCER
     AGENTS THROUGH THE BLADDER
         一一BASIS OF THE INSTILLATION THERAPY－
III． URINARY EXCRETION AND VESICAL TISSUE CONCENTRATION OF THE
 INSTILLED ADRIAMYCIN IN THE PATIENTS WITH BLADDER CANCER
           Kazuo NAGATA
Ft一・m the DePartment ・f伽～・9．ッ，｝’amaguchi Uni乙，ers妙Sch・・1げ焼砒珈
         （Chairman： Prof． ．1． Sakatoku）
  The absorption of adriamycin through the human bladder was studied，狐d f（）llowing results
were obtained：
  1． Urinary excretion of the instilled adriamycSn．
  Studies were made concerning 4 ’cases in which urinary diversion was forced by progressive vesical
carcinoma． After the instillation of adriamycin （60 mg／20 nd saline） over a one hour period， blood
samples and the urine were collected every hour for 6 hours． The blood concentrations of adriamycin
after the instillation were trace． Concerning the amount of adriamycin excreted into the ur－ine of
patients with urinary diverstion， e．41 ±一 e．190／． was excreted druing 6 hours on average．
  2． Tissue concentration of adriamycin in patients with vesical cancer．
  Eighteen patients with vesical carcinoma were examined． Microscopic examination established
a dignosis of trasitional cell carcinoma in 14 cases and anaplastic carcinoma in 4 cases． Adriamycin
（60 mg／20 ml saiine） was instiHed in the bladder． One hour later， the tumDrs were eollected by TUR
cr cystectorny．
  Th・average c・ncent・ati・n・f・d・i・my・i・i・th・tissu…fth・bl・dder carci・・m・w・r l O・3士14・4
ptg／g． The average concentration of transitional cell carcinoma was 5．3±4．5 ptg／g and that of ana－
plastic carcinoma．was 27．1士21．8 pg／g．
































 症例1：79歳の男性．stage C， grade IVの移行上
皮癌のため回腸導管術を施行した．
 症例2：78歳の男性．stagc C， grade IVの移行上
皮癌で，右下機能腎，左水腎症となったため，左尿管
皮膚痩術を施行した．
 症例3：67歳の男性．stage D， grade IVの移行上
皮癌のため回腸導管術を施行した，
 症例4：53歳の男性．stage D， grade IVの移行上
皮癌で尿管皮膚痩術を施行した．
 2）方法







































Table 1．Blood levels and urinary recovery rates of the instilled
adriamycin in patients with urinary diversion．
…eA・・SexH・蜘U撃薗普Bn Blood levelsUrinarv recovelh 2h 3h 6h O－lh 1－2h 2－3h 3－6h
         IlealF．A． 79 M  丁rans．         conduit0000品期品溜（ど搬（窃i揚
G．S． 78 M Trans． fi，”，t？，”，e，O，V，S．yO     11．40 o o
    （O． 02 9e）
53．8 21．6 34．0
（O． 09 9e） （O． ca 90） ｛O． ca ero）
s．t 67 M Anapi． iiモ?aAр浮奄      27．40 0 0
     （o． os or，）
2．8 29．0 53．0
O． ou 70｝ （O． ce Ve） （O． 09 9e）
．K． s3 M Trans． ：Vjta，”，e，O，V，S．yo    10．40 0
   ｛O．02 oro｝
56．2 55．8 108．8































 1 2 3 4 5 6 hrs．
          丁ime after inStillation     M±SD
Urinary recovery of the instilied adriamycin in
patients with urinary diversion （n＝4）
Adriamycin levels in blood and bladder carcinorna
tissue after instillation for 1 hour．
Case Age Sex eqt mor Recovery ratesHistology Grade of the instilled ADM
 Blood levels         Tissue ievels
































































































































































Table 3． Histology and adriamycin levels in
     bladder carcinoma tissue．
N・・・…es・・・…9・Tlssりeﾖ【δRec。ve「y期
i4 T． c． c． 5． 5±4．5pug／g 56．OM 4．1 010















































Table 4．Adriamycin levels in bladder carcinoma tissue after
instillation for 1 hour．
Cose Age Sex His十〇10qy Operation
Blood levels Tissue levels
lhour later Superficial Middle Profound
          畳H，T 54 M Anapl．
S．1． 34 M ’T，c，c．
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